CHINARES PHARMA Sets 24 Aug 2026 Board Meeting to Approve 1H26 Results and Possible Interim Dividend

Bulletin Express08-12

China Resources Pharmaceutical Group Limited (abbreviated as CHINARES PHARMA) announced that its board of directors will meet on 24 August 2026. The session will focus on two main agenda items:

1. Reviewing and approving the unaudited interim results for the six months ended 30 June 2026, along with authorising their publication.

2. Considering the declaration of an interim dividend for the period under review.

The meeting will be chaired by Mr. Bai Xiaosong, who also serves as the company’s Chairman and executive director. The announcement was issued from the People’s Republic of China on 12 August 2026. CHINARES PHARMA’s board currently comprises four executive directors, five non-executive directors and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment